Based on Light GBM, the model achieved an AUC of 0.67 and a recall of 0.90 on the test set, demonstrating its effectiveness in accurately determining MGMT status and reducing false negatives, key factors for a predictive biomarker test. This evidence concerns the gene MGMT and glioblastoma.